title: Effect of the oral intake of probiotic Pediococcus acidilactici BA28 on Helicobacter pylori causing peptic ulcer in C57BL/6 mice models.
abstract: Probiotic lactic acid bacteria are being proposed to cure peptic ulcers by reducing colonization of Helicobacter pylori within the stomach mucosa and by eradicating already established infection. In lieu of that, in vitro inhibitory activity of pediocin-producing probiotic Pediococcus acidilactici BA28 was evaluated against H. pylori by growth inhibition assays. Further, chronic gastritis was first induced in two groups of C57BL/6 mice by orogastric inoculation with H. pylori with polyethylene catheter, and probiotic P. acidilactici BA28 was orally administered to study the eradication and cure of peptic ulcer disease. H. pylori and P. acidilactici BA28 were detected in gastric biopsy and fecal samples of mice, respectively. A probiotic treatment with P. acidilactici BA28, which is able to eliminate H. pylori infection and could reverse peptic ulcer disease, is being suggested as a co-adjustment with conventional antibiotic treatment. The study provided an evidence of controlling peptic ulcer disease, by diet mod
authors.forename: Baljinder
authors.initials: B
authors.lastname: Kaur
authors.forename: Neena
authors.initials: N
authors.lastname: Garg
authors.forename: Atul
authors.initials: A
authors.lastname: Sachdev
authors.forename: Balvir
authors.initials: B
authors.lastname: Kumar
mesh_terms: D000284:Administration, Oral; D000818:Animals; D001430:Bacteriocins / Q000494:pharmacology; D015169:Colony Count, Microbial; D004195:Disease Models, Animal; D005243:Feces / Q000382:microbiology; D005260:Female; D016480:Helicobacter pylori / Q000254:growth & development / Q000502:physiology*; D006801:Humans; D051379:Mice; D008810:Mice, Inbred C57BL; D008826:Microbial Sensitivity Tests; D010376:Pediococcus / Q000737:chemistry*; D010437:Peptic Ulcer / Q000188:drug therapy* / Q000382:microbiology* / Q000473:pathology; D019936:Probiotics / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use*; D013270:Stomach / Q000187:drug effects / Q000382:microbiology / Q000473:pathology
chemical_list: D001430:Bacteriocins